A 360-degree view of the health care sector. This page highlights a small sample of our full coverage. For real-time access, please log in to your Health Care Intelligence Service.

Want full access to Health Care Sector Intelligence

Trending Chart

Interactive chart with headline count

Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order industry coverage for our clients. Contact us for a free consultation.

An example of a few headlines sent to our customers on Jul, 15 2022
Health Care Sector

powered by Industry Intelligence, Inc.

July 15, 2022

Industry Roundup

Cannabis Packaging

Cannabis edibles brand Wyld selects petite flexible pouch with child-resistant zipper for launch of its gummies in Canada in late 2021; pouch is fully compostable and biodegradable, made from bio-based polybutylene succinate, wood pulp and bio-resins
Healthcare Packaging (07/13)

Cold Chain Logistics

North America-based temperature-controlled truckload carrier KLLM Transport Services acquires Cartersville, Georgia-based refrigerated carrier Quest Global to enhance service offerings nationwide; carrier to be re-branded as KLLM Expedited Services
Florida Newswire (07/14)

Freight network East West Holdings agrees to acquire a 37.5% Stake in cold chain logistics solutions company Unique Air Freight Express and Logistics for 40M Indian rupees; move to help East West diversify its existing business
Marketline - Deals (07/14)

Digital Medicine/Telemedicine

GlobalData sees rise in telemedicine product launches over next couple of years, up 262% to 257 in 2023 from 2021; pandemic has accelerated adoption of telemedicine, which is increasingly used to treat neurological, respiratory, cardiovascular diseases
GlobalData Plc (07/12)

Men's Health Issues

Orion partners with Merck to co-develop, commercialize Orion’s oral, non-steroidal inhibitor ODM-208 and other drugs to treat metastatic castration-resistant prostate cancer; deal includes US$290M payment from Merck to Orion
Business Wire (07/14)

Pharmaceutical Ingredients

W. R. Grace to expand contract development and manufacturing facility in South Haven, Michigan; project supports manufacture of small molecule drugs, custom active pharmaceutical ingredients
GlobeNewswire (07/13)

Evonik announces global availability of the EUDRACAP enteric ready-to-fill capsules; product offers protection for complex drug formulations used in clinical trials
Evonik Industries AG (07/12)

Temperature Controlled Packaging

Sonoco ThermoSafe and Turkish Airlines sign global master lease agreement for new Pegasus ULD temperature-controlled bulk shipping container; agreement enables pharmaceutical freight forwarders access to Pegasus ULD containers directly from Turkish Cargo
Sonoco Products Co. (07/14)

Women's Health Issues

FDA removes hold on Greenwich LifeSciences’ Phase 3 study of injectable GLSI-100 to treat breast cancer in patients with residual disease or who have high risk of disease returning; FDA placed initial hold due to manufacturing, pharmacy issues
SeeNews Pharmaceuticals (07/13)

Pregnant women exposed to multiple phthalates during pregnancy have increased risk of preterm birth, according to NIH research; most consistent findings were related to a phthalate used in personal care products including nail polish, cosmetics
ENP Newswire (07/12)

Health Care, Pharmaceuticals & Wellness

Euromonitor: Inflation facilitates shift to healthier behavior, but threatens personalized health care, manufacturing of medicinal products that embrace Industry 4.0; these trends can slow due to growing input prices, consumers choosing cheaper products
Euromonitor International Ltd. (07/14)

Global immunoassay market projected to be worth US$45.8B by 2030, with 7.3% CAGR growth from 2020-2030; growth driven by rise in infectious diseases and cancer, aging population, increasing automation in medicine
Financial Services Monitor Worldwide (07/14)

Novartis buys Mallinckrodt’s FDA priority review voucher for US$100M to speed up future FDA drug applications; voucher shortens FDA’s drug review process from 10 months to six months
Indian Pharma Industry : Policies (07/14)

Health Care & Wellness group

Innoviva to acquire remaining 40% stake in clinical-stage biopharmaceutical company Entasis Therapeutics for US$2.20 per share; upon close of deal Entasis to become wholly owned subsidiary of Innoviva
Marketline - Deals (07/14)

Specialty pharmaceutical firm Neuraxpharm to acquire 15 CNS disorder products, two pain and vascular disease products from Sanofi; the products are well-established in over 50 countries, will boost Neuraxpharm’s annual sales to about €6B
Marketline - Deals (07/14)

Moderna starts Phase 1 trial of experimental Nipah virus vaccine developed with NIAID’s Vaccine Research Center; the respiratory virus was first detected in 1999 in Malaysia and causes acute infection, has estimated death rate of 40% to 75%
SeeNews Pharmaceuticals (07/14)

Pharmaceuticals, Biotechnology & Life Sciences group

Teva and Allergan reach US$54M opioid lawsuit settlement with San Francisco requiring companies to pay the city US$34M in cash, provide US$20M worth of overdose reversal drug Narcan; Walgreens is only remaining defendant in lawsuit
SeeNews Pharmaceuticals (07/14)

Siga Technologies receives US$2M order from Europe, Asia, US$26M order from Canada for its oral smallpox antiviral Tpoxx tecovirimat, which can treat monkeypox; Siga has received international orders worth US$56M for Tpoxx to date
SeeNews Pharmaceuticals (07/14)

Vertex to merge with biotechnology company ViaCyte for US$320M, with ViaCyte to become wholly-owned subsidiary of Vertex upon completion of deal; ViaCyte developing novel stem cell therapies as possible cure for type 1 diabetes
Marketline - Deals (07/13)

 Medical

Hospital/Clinical Devices

B. Braun Medical introduces Introcan Safety 2 IV Catheter with one-time blood control septum to restrict blood flow from catheter after needle removal until connection to access device; CDC estimates caregivers suffer 385,000 sharps injuries annually
PR Newswire (07/14)

GlobalData projects China's medical devices market to top US$42B in 2022, making up 8.3% global market; China expected to continue expanding its market due to aging population, tech improvements, development of clinic/hospital services in wake of pandemic
GlobalData Plc (07/12)

Diagnostic Tests/Monitoring Devices

Zipline partners with Washington-based not-for-profit healthcare organization MultiCare Health System to launch state’s first commercial drone deliveries; service to begin in Tacoma area in 2024 and will deliver lab samples, medications and test kits
GlobeNewswire (07/14)

Respiratory/Lung Health

Biopharmaceutical firm Veru’s experimental oral sabizabulin cancer drug may reduce risk of death in COVID-19 patients by 55% by reducing lung inflammation; Veru has applied for FDA emergency use authorization for drug: New England Journal of Medicine
The Breeze (James Madison University) (07/12)

FDA declines emergency use authorization for Nrx Pharmaceuticals’ injectable Zyesami aviptadil COVID-19 therapy for patients at immediate risk of death from respiratory failure; company to evaluate options for Zyesami after it receives data from NIH
SeeNews Pharmaceuticals (07/12)

Pumps/Syringes/Infusion Supplies

Utah-based Compax releases fully recyclable, all plastic airless pump tube in the US market; company currently has production running on both its new 30mm and 35mm airless tubes, and is working to convert its entire line of airless tube diameters
PR Newswire (07/12)

Hospital/Medical Use

German fiber producer AMSilk to scale-up production of biobased silk materials by several thousand tons/year, expand production network outside of Europe; company makes artificial spider silk for fiber, medical device, hydrogel, cosmetics, food industries
AMSilk GmbH (07/14)

Scientists develop electrospun nanofiber wound dressing to promote healing; dressing delivers antibiotic ciprofloxacin, zinc oxide, with top layer composed of biodegradable polycaprolactone, middle made of Janus nanofibers, bottom of hydrophilic gelatin
NewsRx Drug Daily (07/13)

Health Care, Pharmaceuticals & Wellness

Chinese company Xianie Health and its dietary supplement subsidiary Sirio Healthcare Holdings acquire 80% equity stake in US-based Best Formulations, a supplement product, contract development, manufacturing firm, for US$180M
Marketline - Deals (07/13)

US HHS secures 3.2 million doses of Novavax COVID-19 vaccine to offer another vaccine option this fall; FDA has not yet approved drug, although advisory panel endorsed the protein-based shot in June, which is given in two doses 21 days apart
The Washington Times (07/13)

 Pharma

Over-the-Counter (OTC) Drugs

Altamira Therapeutics receives FDA 510(k) clearance for OTC Bentrio nasal spray to treat allergic rhinitis, also known as hay fever, with product becoming available online in Q3; in US more than 20 million people suffer from hay fever
Accesswire (07/12)

Perrigo's HRA Pharma submits application to FDA to switch Opill daily birth control pill from prescription-only to OTC; if approved, Opill would be first OTC birth control pill in US, where every year 6.1 million pregnancies are unintentional
CE Noticias Financieras (07/12)

Hospital/Clinical Drugs

Genentech expands immune-oncology collaboration with Bicycle Therapeutics that started in 2020 with milestone payment of US$10M; Bicycle handles drug discovery, R&D, pre-clinical development, Genentech develops, commercializes drug candidates
SeeNews Pharmaceuticals (07/13)

Macrogenics stops mid-stage trial evaluating injectable enoblituzumab in combination with retifanlimab or tebotelimab to treat head, neck cancer after deaths of seven participants; deaths associated with bleeding events
SeeNews Pharmaceuticals (07/12)

Vaccination/Immunization

Moderna reports its bivalent COVID-19 booster candidate mRNA-1273.214 triggered higher antibody response against Omicron than authorized booster; Moderna to advance two booster candidates this fall based on market preferences for Omicron variants
SeeNews Pharmaceuticals (07/13)

FDA grants full approval of Pfizer and Biontech’s Comirnaty COVID-19 vaccination for kids between 12-years, 15-years old; 9 million kids in US have received primary doses under emergency use authorization, with drug generating Q1 sales of US$13.2B
PharmaBiz (07/12)

Health Care, Pharmaceuticals & Wellness

Roche receives global license to advance Ionis Pharmaceuticals’ injectable IONIS-FB-LRX to treat kidney disease for US$55M; drug based on Ionis’ antisense technology, has potential to treat other inflammatory conditions
SeeNews Pharmaceuticals (07/13)

Global non-invasive ventilator market projected to reach US$2.85B in 2030, with CAGR growth of 5.91% during study period with surge in chronic conditions driving growth: 51.8% of US adults have at least one chronic condition or disease
Financial Services Monitor Worldwide (07/13)

 Packaging

Health Care & Medical Packaging

Kuehne+Nagel launches MedConnex healthcare air charters from Liege, Belgium, to Americas, Asia and Africa; solution utilizes its Liege Airport and Brussels Airport hubs, which offers temperature-controlled warehousing, special packaging materials
Kuehne+Nagel (07/12)

Caps & Closures

UK brand Trepadora selects Spectra’s 300ml Roma bottle in 100% PCR HDPE, paired with a disc top closure, for its curl therapy hair care products; bottles are color matched with two-pass silkscreen print
Spectra Packaging Ltd. (07/13)

Silgan Holdings, Crown Holdings fined €31.5M by the European Commission for participation in a cartel regarding the sales of metal cans, closures in Germany; probe was started in 2015 by the German antitrust authority, was transferred in 2018 to the EC
CE Noticias Financieras (07/12)

Lidding

Zume and Transcend Packaging to collaborate on enhancing capacity of wet molded-fiber snap lids for beverage cups on a large scale in Europe; site assessments regarding exact location are being conducted, with aim of being fully functional by mid-2023
Webwire (07/14)

 Stock

Latest: Jul, 14 2022

Latest Value Prev Chg YOY Chg
Watchlist
Abbott Laboratories (ABT) 105.71 106.21 -0.47% -9.78%
Cardinal Health (CAH) 54.05 52.90 2.17% -5.29%
Johnson & Johnson (JNJ) 175.68 175.44 0.14% 3.09%
Merck & Co. Inc. (MRK) 93.88 93.77 0.12% 20.95%
SAMPLE REPORT